NASDAQ:BMEA

Biomea Fusion Stock Predictions

etoro logo Buy BMEA
*Your capital is at risk
$1.30
-0.0700 (-5.11%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BMEA Prediction Chart

BMEA Predictions History

Latest community submissions for BMEA.
Predictor Target Session Target Price Result Direction Accuracy Score
May 4, 2026 $1.42 +4.00% $1.48 V 96.27% 1
May 4, 2026 $1.43 +4.43% $1.48 V 96.67% 1
May 4, 2026 $1.41 +2.77% $1.48 V 95.13% 1
May 4, 2026 Bearish $1.48 X 0
Apr 8, 2026 Bullish $1.76 X 0
Mar 6, 2026 $1.33 -2.90% $1.39 X 95.70% 0
Mar 6, 2026 $1.39 +1.81% $1.39 V 99.65% 5
Feb 2, 2026 $1.16 +3.78% $1.10 X 94.34% 0
Feb 2, 2026 $1.15 +2.36% $1.10 X 95.78% 0
Feb 2, 2026 Bullish $1.10 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BMEA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOMEA FUSION, INC.
Biomea Fusion
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in R...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE